A record to read carefully
Semaglutide: evidence profile
Approved product · Randomized evidence
Read the product, route and approval scope together. A category label does not replace those details. Use the exercise to prepare questions, not to choose a treatment.
Evidence record
- Product and route
- This entry covers subcutaneous Wegovy injection.
- Approval scope
- Wegovy injection: weight management in eligible adults.
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limits
- Check other products separately.
- Safety context
- Severe or persistent gastrointestinal symptoms: contact a clinician.
Try this while reading
A screenshot can lose the small heading that explains a result. When saving a semaglutide discussion, add a sentence that spells out what the number measures and the unit attached to it. If a percentage appears, look for the amount or group used to calculate it. Try explaining the result aloud without saying just the number. Could a listener mistake a change in an amount for a change in a percentage? Return to the heading or methods until you can make that distinction. Keep the explanation with your saved image so a future comparison starts with quantities that actually match.
Questions to keep
- What heading must stay with this screenshot for the number to make sense?
- What amount or group is the percentage calculated from?
- Am I comparing the same kind of quantity in both saved results?
Sources to open
- WEGOVY — NLM; checked
- Wegovy approval — FDA; checked